| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.10e-14 | 114 | 78 | 12 | GO:0004843 |
| GeneOntologyMolecularFunction | deubiquitinase activity | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 5.87e-14 | 124 | 78 | 12 | GO:0101005 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.97e-13 | 137 | 78 | 12 | GO:0019783 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.10e-11 | 192 | 78 | 12 | GO:0008234 |
| GeneOntologyMolecularFunction | peptidase activity | USP17L21 SPPL2A USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 MYRF USP17L15 USP17L13 USP17L18 | 2.10e-07 | 654 | 78 | 14 | GO:0008233 |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 4.44e-14 | 125 | 78 | 12 | GO:0016579 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.47e-13 | 144 | 78 | 12 | GO:0070646 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 C10orf90 USP17L19 USP17L22 CNOT4 USP17L15 USP17L13 USP17L18 | 2.25e-05 | 1009 | 78 | 14 | GO:0070647 |
| GeneOntologyBiologicalProcess | post-translational protein modification | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 C10orf90 USP17L19 USP17L22 CNOT4 USP17L15 USP17L13 USP17L18 | 4.46e-05 | 1074 | 78 | 14 | GO:0043687 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | USP17L21 SPPL2A USP17L12 USP17L17 USP17L20 USP17L11 SEC24A RETREG1 USP17L5 USP17L19 GRIN2B TLR9 USP17L22 MYRF USP17L15 USP17L13 USP17L18 | 6.30e-06 | 1293 | 80 | 17 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | USP17L21 SPPL2A USP17L12 USP17L17 USP17L20 USP17L11 SEC24A RETREG1 USP17L5 USP17L19 GRIN2B TLR9 USP17L22 MYRF USP17L15 USP17L13 USP17L18 | 6.70e-06 | 1299 | 80 | 17 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | USP17L21 SPPL2A USP17L12 USP17L17 USP17L20 USP17L11 SEC24A RETREG1 USP17L5 USP17L19 GRIN2B TLR9 USP17L22 MYRF USP17L15 USP17L13 USP17L18 | 8.88e-06 | 1327 | 80 | 17 | GO:0042175 |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 2.29e-04 | 78 | 80 | 4 | GO:0048787 | |
| GeneOntologyCellularComponent | presynaptic endosome | 3.00e-04 | 7 | 80 | 2 | GO:0098830 | |
| Domain | HABP4_PAI-RBP1 | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L13 USP17L18 | 1.39e-23 | 16 | 78 | 11 | PF04774 |
| Domain | HABP4_PAIRBP1-bd | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L13 USP17L18 | 1.39e-23 | 16 | 78 | 11 | IPR006861 |
| Domain | USP_CS | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L13 USP17L18 | 2.89e-15 | 66 | 78 | 11 | IPR018200 |
| Domain | USP_1 | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L13 USP17L18 | 5.75e-15 | 70 | 78 | 11 | PS00972 |
| Domain | UCH | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L13 USP17L18 | 6.78e-15 | 71 | 78 | 11 | PF00443 |
| Domain | USP_2 | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L13 USP17L18 | 6.78e-15 | 71 | 78 | 11 | PS00973 |
| Domain | USP_3 | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L13 USP17L18 | 7.98e-15 | 72 | 78 | 11 | PS50235 |
| Domain | USP_dom | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L13 USP17L18 | 7.98e-15 | 72 | 78 | 11 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L13 USP17L18 | 7.98e-15 | 72 | 78 | 11 | IPR001394 |
| Domain | GPCR_2_secretin-like | 1.15e-04 | 60 | 78 | 4 | IPR000832 | |
| Domain | GPCR_2-like | 1.15e-04 | 60 | 78 | 4 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 1.23e-04 | 61 | 78 | 4 | PS50261 | |
| Domain | GPS | 3.82e-04 | 34 | 78 | 3 | SM00303 | |
| Domain | GPCR_2_secretin-like_CS | 3.82e-04 | 34 | 78 | 3 | IPR017983 | |
| Domain | GPS | 4.17e-04 | 35 | 78 | 3 | PF01825 | |
| Domain | GPS | 4.53e-04 | 36 | 78 | 3 | PS50221 | |
| Domain | GPS | 4.92e-04 | 37 | 78 | 3 | IPR000203 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 1.19e-03 | 50 | 78 | 3 | PS00650 | |
| Domain | 7tm_2 | 1.19e-03 | 50 | 78 | 3 | PF00002 | |
| Domain | - | 3.77e-03 | 22 | 78 | 2 | 3.40.50.1440 | |
| Domain | Tubulin_FtsZ_GTPase | 4.48e-03 | 24 | 78 | 2 | IPR003008 | |
| Domain | Tubulin | 4.48e-03 | 24 | 78 | 2 | PF00091 | |
| Pathway | REACTOME_RAS_PROCESSING | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 6.16e-17 | 45 | 64 | 11 | MM15671 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.62e-10 | 221 | 64 | 12 | M27578 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 8.42e-10 | 191 | 64 | 11 | MM15289 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 8.16e-09 | 299 | 64 | 12 | M27574 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.31e-08 | 262 | 64 | 11 | MM15286 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.66e-07 | 318 | 64 | 11 | MM15278 |
| Pubmed | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L5 USP17L19 TLR9 USP17L22 USP17L15 USP17L13 USP17L18 | 4.69e-26 | 25 | 80 | 12 | 21115691 | |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.61e-24 | 21 | 80 | 11 | 8622927 |
| Pubmed | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.61e-24 | 21 | 80 | 11 | 14583620 | |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.61e-24 | 21 | 80 | 11 | 11468161 |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.61e-24 | 21 | 80 | 11 | 8756639 |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.61e-24 | 21 | 80 | 11 | 12447969 |
| Pubmed | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.61e-24 | 21 | 80 | 11 | 18980247 | |
| Pubmed | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 3.15e-24 | 33 | 80 | 12 | 20228807 | |
| Pubmed | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 3.22e-24 | 22 | 80 | 11 | 9154835 | |
| Pubmed | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 4.86e-24 | 34 | 80 | 12 | 20403174 | |
| Pubmed | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 4.86e-24 | 34 | 80 | 12 | 17109758 | |
| Pubmed | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 4.86e-24 | 34 | 80 | 12 | 20388806 | |
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 4.86e-24 | 34 | 80 | 12 | 14699124 |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 4.86e-24 | 34 | 80 | 12 | 20715989 |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 4.86e-24 | 34 | 80 | 12 | 9806828 |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 4.86e-24 | 34 | 80 | 12 | 20368735 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 4.86e-24 | 34 | 80 | 12 | 15780755 |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 4.86e-24 | 34 | 80 | 12 | 19188362 |
| Pubmed | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 4.86e-24 | 34 | 80 | 12 | 11941478 | |
| Pubmed | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 4.86e-24 | 34 | 80 | 12 | 10936051 | |
| Pubmed | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 4.86e-24 | 34 | 80 | 12 | 21448158 | |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 7.39e-24 | 35 | 80 | 12 | 16611142 |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 7.39e-24 | 35 | 80 | 12 | 21239494 |
| Pubmed | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.11e-23 | 36 | 80 | 12 | 20147298 | |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.13e-23 | 24 | 80 | 11 | 8995226 |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.63e-23 | 37 | 80 | 12 | 20228808 |
| Pubmed | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 3.50e-23 | 26 | 80 | 11 | 35816173 | |
| Pubmed | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.56e-22 | 29 | 80 | 11 | 32527007 | |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.62e-19 | 50 | 80 | 11 | 31806660 |
| Pubmed | TET2 USP17L21 USP17L12 PSG1 USP17L17 USP17L20 USP17L11 NAV2 USP17L5 USP17L19 USP17L22 TAF1L USP17L15 USP17L13 USP17L18 | 3.63e-11 | 674 | 80 | 15 | 37196079 | |
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L19 USP17L18 | 1.19e-08 | 119 | 80 | 7 | 28625976 |
| Pubmed | Prenatal stress disturbs hippocampal KIF17 and NR2B in spatial cognition in male offspring. | 5.23e-06 | 2 | 80 | 2 | 23239421 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 21521616 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 24836181 | ||
| Pubmed | KIF17 Modulates Epileptic Seizures and Membrane Expression of the NMDA Receptor Subunit NR2B. | 5.23e-06 | 2 | 80 | 2 | 35678994 | |
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 22264824 | ||
| Pubmed | SALM4 negatively regulates NMDA receptor function and fear memory consolidation. | 1.57e-05 | 3 | 80 | 2 | 34588597 | |
| Pubmed | KIF17 dynamics and regulation of NR2B trafficking in hippocampal neurons. | 1.57e-05 | 3 | 80 | 2 | 12514209 | |
| Pubmed | DNA hypermethylation is associated with invasive phenotype of malignant melanoma. | 1.57e-05 | 3 | 80 | 2 | 31602702 | |
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 21172391 | ||
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 26085624 | ||
| Pubmed | Embryonic demise caused by targeted disruption of a cysteine protease Dub-2. | 3.13e-05 | 4 | 80 | 2 | 22984479 | |
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 1572651 | ||
| Pubmed | Bifurcation of Toll-like receptor 9 signaling by adaptor protein 3. | 3.13e-05 | 4 | 80 | 2 | 20847273 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 4.99e-05 | 283 | 80 | 6 | 30585729 | |
| Pubmed | 5.00e-05 | 87 | 80 | 4 | 12465718 | ||
| Pubmed | 5.20e-05 | 5 | 80 | 2 | 20231379 | ||
| Pubmed | 5.20e-05 | 5 | 80 | 2 | 2377620 | ||
| Pubmed | International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors. | 6.08e-05 | 33 | 80 | 3 | 25713288 | |
| Pubmed | Loss of polycystin-1 inhibits Bicc1 expression during mouse development. | 7.79e-05 | 6 | 80 | 2 | 24594709 | |
| Pubmed | ENU mutagenesis in mice identifies candidate genes for hypogonadism. | 1.09e-04 | 7 | 80 | 2 | 22258617 | |
| Pubmed | Characterization of cDNA encoding novel pregnancy-specific glycoprotein variants. | 1.09e-04 | 7 | 80 | 2 | 7794280 | |
| Pubmed | 1.45e-04 | 8 | 80 | 2 | 20215348 | ||
| Pubmed | 1.45e-04 | 8 | 80 | 2 | 37315734 | ||
| Pubmed | TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. | 2.32e-04 | 10 | 80 | 2 | 21490601 | |
| Pubmed | Kinesin superfamily motor protein KIF17 and mLin-10 in NMDA receptor-containing vesicle transport. | 3.40e-04 | 12 | 80 | 2 | 10846156 | |
| Pubmed | 3.40e-04 | 12 | 80 | 2 | 11700294 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 3.44e-04 | 954 | 80 | 9 | 36373674 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 3.60e-04 | 759 | 80 | 8 | 35915203 | |
| Pubmed | 3.93e-04 | 268 | 80 | 5 | 33640491 | ||
| Pubmed | 4.01e-04 | 13 | 80 | 2 | 17707232 | ||
| Pubmed | TET2 NCOA6 LARP4B ZBTB33 MYO5A RBM10 SEC24A GMEB1 POU2F1 TAF1L SAP130 | 4.21e-04 | 1429 | 80 | 11 | 35140242 | |
| Pubmed | 4.39e-04 | 153 | 80 | 4 | 10718198 | ||
| Pubmed | 4.86e-04 | 794 | 80 | 8 | 11076863 | ||
| Pubmed | Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. | 5.03e-04 | 283 | 80 | 5 | 18854154 | |
| Pubmed | 5.38e-04 | 15 | 80 | 2 | 21029969 | ||
| Pubmed | 5.38e-04 | 15 | 80 | 2 | 22658931 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | TRIM66 DONSON MYO5A SEC24A COQ9 C10orf90 SAP130 CNOT4 ADGRD1 ATPAF2 | 5.54e-04 | 1242 | 80 | 10 | 30973865 |
| Pubmed | 6.14e-04 | 16 | 80 | 2 | 24305805 | ||
| Pubmed | Study of 18 functional hemostatic polymorphisms in mucocutaneous bleeding disorders. | 6.14e-04 | 16 | 80 | 2 | 20532885 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 6.59e-04 | 457 | 80 | 6 | 32344865 | |
| Pubmed | 6.95e-04 | 17 | 80 | 2 | 26627310 | ||
| Pubmed | Fetal inhibition of inflammation improves disease phenotypes in harlequin ichthyosis. | 6.95e-04 | 17 | 80 | 2 | 25209981 | |
| Pubmed | 8.71e-04 | 19 | 80 | 2 | 20219685 | ||
| Pubmed | 9.43e-04 | 83 | 80 | 3 | 28794006 | ||
| Pubmed | Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1. | 9.66e-04 | 20 | 80 | 2 | 17251353 | |
| Pubmed | TUBB1 mutations cause thyroid dysgenesis associated with abnormal platelet physiology. | 1.17e-03 | 22 | 80 | 2 | 30446499 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.24e-03 | 202 | 80 | 4 | 33005030 | |
| Pubmed | Isoform-specific GSK3A activity is negatively correlated with human sperm motility. | 1.27e-03 | 92 | 80 | 3 | 30824926 | |
| Pubmed | The small GTPase Rac1 regulates auditory hair cell morphogenesis. | 1.28e-03 | 23 | 80 | 2 | 20016102 | |
| Pubmed | 1.28e-03 | 23 | 80 | 2 | 20207250 | ||
| Pubmed | 1.36e-03 | 720 | 80 | 7 | 16381901 | ||
| Pubmed | 1.38e-03 | 722 | 80 | 7 | 15489336 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 1.44e-03 | 358 | 80 | 5 | 32460013 | |
| Pubmed | SALM4 suppresses excitatory synapse development by cis-inhibiting trans-synaptic SALM3-LAR adhesion. | 1.51e-03 | 25 | 80 | 2 | 27480238 | |
| Pubmed | In vivo validation of late-onset Alzheimer's disease genetic risk factors. | 1.51e-03 | 25 | 80 | 2 | 38687251 | |
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | 1.61e-03 | 100 | 80 | 3 | 25807483 | |
| Pubmed | CS NWD2 MYO5A SNAP91 PRR36 ZNFX1 CLASP2 GRIN2B SNRNP200 AP3D1 | 1.62e-03 | 1431 | 80 | 10 | 37142655 | |
| Pubmed | 1.69e-03 | 549 | 80 | 6 | 38280479 | ||
| Pubmed | 1.72e-03 | 551 | 80 | 6 | 34728620 | ||
| Pubmed | 1.90e-03 | 28 | 80 | 2 | 24836286 | ||
| Pubmed | 1.90e-03 | 28 | 80 | 2 | 8672132 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 2.02e-03 | 231 | 80 | 4 | 16452087 | |
| Pubmed | The human and mouse repertoire of the adhesion family of G-protein-coupled receptors. | 2.04e-03 | 29 | 80 | 2 | 15203201 | |
| Pubmed | 2.09e-03 | 777 | 80 | 7 | 35844135 | ||
| Interaction | FLT3 interactions | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L19 TAF1L AP3D1 USP17L18 | 3.80e-06 | 318 | 78 | 9 | int:FLT3 |
| Cytoband | 4p16.1 | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.54e-20 | 79 | 80 | 12 | 4p16.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 5.47e-15 | 222 | 80 | 12 | chr4p16 |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 2.34e-04 | 11 | 38 | 2 | 1315 | |
| Coexpression | MADAN_DPPA4_TARGETS | USP17L21 USP17L12 SNAP91 USP17L17 USP17L20 USP17L11 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 3.00e-17 | 86 | 79 | 12 | MM1312 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 3.72e-14 | 112 | 79 | 11 | MM1095 |
| Coexpression | GERY_CEBP_TARGETS | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 1.96e-12 | 160 | 79 | 11 | MM1155 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 PPP1R37 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 5.24e-07 | 647 | 79 | 12 | MM981 |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | USP17L21 DONSON USP17L12 MYO5A USP17L17 USP17L20 USP17L11 SLIT3 USP17L5 USP17L19 USP17L22 USP17L15 BICC1 USP17L13 USP17L18 | 2.50e-06 | 1198 | 79 | 15 | MM1062 |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | USP17L21 USP17L12 MYO5A USP17L17 USP17L20 USP17L11 PPP1R37 USP17L5 USP17L19 USP17L22 KIF17 USP17L15 TECPR1 USP17L13 USP17L18 | 3.32e-06 | 1226 | 79 | 15 | MM979 |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 3.99e-05 | 208 | 79 | 6 | M39233 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.01e-06 | 162 | 73 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.37e-06 | 168 | 73 | 5 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.61e-06 | 169 | 73 | 5 | 0425d2580ed325178f522c0093ff4623de6ce7a8 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.61e-06 | 169 | 73 | 5 | fec669968a77060bd77ee8695034e35a642c984f | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.11e-05 | 178 | 73 | 5 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B_plasma-Plasmablasts|Lung / Manually curated celltypes from each tissue | 1.14e-05 | 179 | 73 | 5 | 3fa75eec3e86fd1797eaa33362257df7f9b2a0bf | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-05 | 186 | 73 | 5 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 1.48e-05 | 189 | 73 | 5 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.56e-05 | 191 | 73 | 5 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-05 | 191 | 73 | 5 | 9032aa974aa1b7b1095b8d1b58dcb087358a5001 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-05 | 191 | 73 | 5 | 5717809a1476c20f65bce722c5a57cff92ee0d7a | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-05 | 197 | 73 | 5 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.48e-05 | 145 | 73 | 4 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | URO-Other-RBC|URO / Disease, Lineage and Cell Type | 1.39e-04 | 160 | 73 | 4 | 558f3b0719e2461a69e1b93b08e21675e8d07a5a | |
| ToppCell | URO-Other|URO / Disease, Lineage and Cell Type | 1.39e-04 | 160 | 73 | 4 | b0923e6bacfaba8ca40aa5706bf270eea0938b0a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-04 | 163 | 73 | 4 | 2d6fd2562d78be9f83fa35d811eb7e27eb8cc5d1 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.63e-04 | 167 | 73 | 4 | c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.63e-04 | 167 | 73 | 4 | 351f8de1fbdf742ac74f9099b254d515ab539bb2 | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 1.83e-04 | 172 | 73 | 4 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.87e-04 | 173 | 73 | 4 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.91e-04 | 174 | 73 | 4 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 175 | 73 | 4 | c1c722db42da9b8a2a46e516ddb83d9be5e2e504 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-04 | 177 | 73 | 4 | c9e8149639551a4c8daa90fcb2b895fdcff2e2ba | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.13e-04 | 179 | 73 | 4 | 065a50952e8703fa07767beb6b73a090bf378ca6 | |
| ToppCell | IPF-Epithelial-Mesothelial|IPF / Disease state, Lineage and Cell class | 2.17e-04 | 180 | 73 | 4 | 1fa54bf4dba72866b2295639d991af639341bc08 | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.17e-04 | 180 | 73 | 4 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.17e-04 | 180 | 73 | 4 | 66c7b02d85e32ba3e7530d0c4aff17e7525ccdd8 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.27e-04 | 182 | 73 | 4 | 573771130247e869e4e58f22d4a1cb31989635cf | |
| ToppCell | ASK454-Epithelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.27e-04 | 182 | 73 | 4 | ab15316cff989b61ff397a866d7ca8b49c13e981 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.27e-04 | 182 | 73 | 4 | 6cfaa2b3b3974c13b01c943f4adb70768dcc35e4 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.32e-04 | 183 | 73 | 4 | f079179f2984def91ddf0b33d7949d5ecdbd380d | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.32e-04 | 183 | 73 | 4 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.32e-04 | 183 | 73 | 4 | 49e8ee16e4f677f9f649e2a2faf1b9b16c5a27e7 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.36e-04 | 184 | 73 | 4 | 607b55022de21ddb6a2d75e085df76df7abf6624 | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|tumor_Lung / Location, Cell class and cell subclass | 2.36e-04 | 184 | 73 | 4 | b0a251030d127858e68cf164be158f209a4d720f | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 2.41e-04 | 185 | 73 | 4 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Papillary_Renal_Cell_Carcinoma|TCGA-Kidney / Sample_Type by Project: Shred V9 | 2.41e-04 | 185 | 73 | 4 | 46f4f6f20b1e152922f6f2ba1244c56e48a49b79 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.46e-04 | 186 | 73 | 4 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-04 | 186 | 73 | 4 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|kidney / Disease (COVID-19 only), tissue and cell type | 2.51e-04 | 187 | 73 | 4 | 2ce8038d9d1302e850c1bb536e755598f77ba4b9 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-04 | 187 | 73 | 4 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.57e-04 | 188 | 73 | 4 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 2.57e-04 | 188 | 73 | 4 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.57e-04 | 188 | 73 | 4 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | COVID-19-kidney-DCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.57e-04 | 188 | 73 | 4 | 1d56cd409793f05cca20757ab26e91f1a1ee67b5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.57e-04 | 188 | 73 | 4 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.57e-04 | 188 | 73 | 4 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-04 | 189 | 73 | 4 | f0a2d4ef9896d764971ebbc6952510c128bb76e8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-04 | 189 | 73 | 4 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-04 | 189 | 73 | 4 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-04 | 189 | 73 | 4 | 378f26f751ab4b470948c35dd8347de72dd12ff7 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.62e-04 | 189 | 73 | 4 | 42ab4cc5fbf8580841f31889446fe4499df1a464 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-04 | 189 | 73 | 4 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-04 | 189 | 73 | 4 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-04 | 191 | 73 | 4 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-04 | 191 | 73 | 4 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-04 | 191 | 73 | 4 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.72e-04 | 191 | 73 | 4 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-04 | 191 | 73 | 4 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.72e-04 | 191 | 73 | 4 | 9f478f36a0b895e607e3bb77fa0f9f03cc0f33fc | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.72e-04 | 191 | 73 | 4 | a90c8ab2077e52bbc998457c85a1b9867f9c8c93 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 192 | 73 | 4 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.78e-04 | 192 | 73 | 4 | 0e7e55505bd5454d7cf952a63fdcb46ec76f1973 | |
| ToppCell | COVID-19-kidney-CNT|kidney / Disease (COVID-19 only), tissue and cell type | 2.78e-04 | 192 | 73 | 4 | d32ae226d95b4b6adb99d14b602be09b661d4cd9 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 192 | 73 | 4 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 2.78e-04 | 192 | 73 | 4 | e16035b3328f9b1b2e28d234c62ba88387540550 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.78e-04 | 192 | 73 | 4 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.78e-04 | 192 | 73 | 4 | 790282d4232311df3dac4ad97c80fc53443beccc | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.78e-04 | 192 | 73 | 4 | b2d9bffccd6264b4f12d88a0780646ee0b41969f | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-04 | 193 | 73 | 4 | 858a186804b36d45957238d3d3eed2768b961641 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-04 | 193 | 73 | 4 | 7865e7ec0a288249540d4cba94ae01c93e1b617c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-04 | 193 | 73 | 4 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-04 | 193 | 73 | 4 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.83e-04 | 193 | 73 | 4 | 025836c5c5a711e477c326559e618e47cae42d11 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.83e-04 | 193 | 73 | 4 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.83e-04 | 193 | 73 | 4 | 051f61156b0e2e95292b2d8377faf3190b50f264 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-04 | 194 | 73 | 4 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-04 | 194 | 73 | 4 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-04 | 194 | 73 | 4 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-04 | 194 | 73 | 4 | 70185c0b8e0f4e896645b17a243482ba3cdf4a5d | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.89e-04 | 194 | 73 | 4 | 421344cc4b601d9745fa72d0af3124dab11d1d27 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-04 | 195 | 73 | 4 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-04 | 195 | 73 | 4 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.95e-04 | 195 | 73 | 4 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-04 | 196 | 73 | 4 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | COVID-mDC2|COVID / Condition, Cell_class and T cell subcluster | 3.01e-04 | 196 | 73 | 4 | bb13926bb664be917017edb0ce7f184abe31744b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-04 | 196 | 73 | 4 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | control-Others-Megakaryocytes|Others / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.01e-04 | 196 | 73 | 4 | 10d914f1612622f64ac71da04e1995a854a4bec9 | |
| ToppCell | COVID-mDC2-|COVID / Condition, Cell_class and T cell subcluster | 3.01e-04 | 196 | 73 | 4 | 6d02a4c5c19be7e036150cf945585cf5a773bc87 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-04 | 196 | 73 | 4 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.01e-04 | 196 | 73 | 4 | 34bd155e6d848eb53d613997c0e244535de30ba3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-04 | 196 | 73 | 4 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.06e-04 | 197 | 73 | 4 | 6806ec223e542f0475303698eb78c1cc527f5c6b | |
| ToppCell | COVID-19_Severe-Neu_1|COVID-19_Severe / 5 Neutrophil clusters in COVID-19 patients | 3.12e-04 | 198 | 73 | 4 | bbe639ea5a636c985e509fb0a133ae3b60afac5a | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 3.12e-04 | 198 | 73 | 4 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | (11)_FOXN4+|World / shred by cell type by condition | 3.12e-04 | 198 | 73 | 4 | 516b1acdf997dd8debc3dca066519366e507b414 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Mesenchymal-Cilia-bearing_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 3.18e-04 | 199 | 73 | 4 | 2d8ab4aee300c7c4baf662940ce855da2b6d2cae | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Mesothelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.18e-04 | 199 | 73 | 4 | ca970114b5aef4518ce580897a62ac88688b2671 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.18e-04 | 199 | 73 | 4 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.18e-04 | 199 | 73 | 4 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| Drug | Mesalamine [89-57-6]; Down 200; 26.2uM; MCF7; HT_HG-U133A | 2.24e-06 | 197 | 69 | 7 | 7241_DN | |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.40e-21 | 46 | 80 | 12 | DOID:5426 (implicated_via_orthology) |
| Disease | congenital heart disease (implicated_via_orthology) | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L22 SAP130 USP17L15 USP17L13 USP17L18 | 5.26e-21 | 69 | 80 | 13 | DOID:1682 (implicated_via_orthology) |
| Disease | chronic myelomonocytic leukemia (is_implicated_in) | 7.22e-05 | 5 | 80 | 2 | DOID:0080188 (is_implicated_in) | |
| Disease | red blood cell density measurement | 1.32e-04 | 880 | 80 | 10 | EFO_0007978 | |
| Disease | primary immunodeficiency disease (is_implicated_in) | 2.04e-04 | 42 | 80 | 3 | DOID:612 (is_implicated_in) | |
| Disease | hypothyroidism (implicated_via_orthology) | 5.55e-04 | 13 | 80 | 2 | DOID:1459 (implicated_via_orthology) | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 8.50e-04 | 16 | 80 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | cD177 antigen measurement | 1.08e-03 | 18 | 80 | 2 | EFO_0021866 | |
| Disease | blood phosphate measurement | 1.30e-03 | 174 | 80 | 4 | EFO_0010972 | |
| Disease | response to selective serotonin reuptake inhibitor | 1.46e-03 | 82 | 80 | 3 | EFO_0005658 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 1.56e-03 | 84 | 80 | 3 | DOID:9119 (is_implicated_in) | |
| Disease | beta-amyloid 1-42 measurement | 1.73e-03 | 87 | 80 | 3 | EFO_0004670 | |
| Disease | Dwarfism | 2.09e-03 | 25 | 80 | 2 | C0013336 | |
| Disease | response to TNF antagonist, joint damage measurement | 2.09e-03 | 25 | 80 | 2 | EFO_0004653, EFO_0005413 | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 2.62e-03 | 28 | 80 | 2 | DOID:1094 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| STLHPSTFNQLMISQ | 291 | Q8N5Z0 | |
| QMPGDTLSLTLHLSQ | 246 | Q8IZF5 | |
| SQPMNKHLFVSLSTL | 21 | Q5VVS0 | |
| QLLVAINSTSLTHML | 321 | P22674 | |
| HALLSSTLPSLFMTS | 251 | Q6QNK2 | |
| NMTTLLANASLNLHS | 406 | P48960 | |
| SSDIHTPAQMLLSTL | 131 | Q9H2A7 | |
| PSSLMETLEQHLNTL | 271 | O60641 | |
| HLMIPSTAQATLTNI | 516 | Q9H694 | |
| EPLTNLIHSTSAMSL | 261 | O14617 | |
| HNMLLSLSTSGVLSI | 1286 | Q9ULI1 | |
| TIILRNLNPHSTMDS | 301 | P98175 | |
| MHLTTLCNTSLDNPT | 106 | Q8N5M1 | |
| HPSSSLALLSSTAMQ | 466 | Q9Y692 | |
| SSLPNHMPSSINLLV | 296 | Q86T24 | |
| HLMNGPISQTTSQTS | 26 | Q92615 | |
| QQQPGVMSSSHLLLT | 456 | Q9BUK6 | |
| GPALSHLVSQTTAQM | 551 | Q9HCD5 | |
| TSTIPLSMAATLQHS | 246 | Q8WU58 | |
| SMLTGTQSLLQPHLE | 581 | Q5TB30 | |
| HSQMGSLNSQLISTL | 856 | Q14678 | |
| NMTGLLHLSLSRNTI | 81 | Q9BTN0 | |
| SSLSIITELTHPANM | 831 | Q6UVM3 | |
| SDSSQTLPSMVHLIQ | 281 | O94927 | |
| PLSHRNSLDTNLTSM | 186 | Q06190 | |
| LSPALMSNSTLATIQ | 626 | P14859 | |
| GMTLPHTQSLETLNL | 326 | O75864 | |
| NTSAALPTHLQSALM | 1611 | Q14686 | |
| LASTTMNLTSPLLQC | 1816 | Q92794 | |
| PKMLSNFLSRQHTIS | 81 | Q8NH40 | |
| NLHPMSQLSAAVTAL | 161 | O75390 | |
| PHNLSCLMNLTTSSL | 126 | Q99062 | |
| LHSLTMLLKSSQSGS | 481 | Q9NYP3 | |
| SSIRDLSNNPMTHIT | 636 | Q9NPG1 | |
| HNIPSSLSLLTSMVD | 211 | O75208 | |
| VTSASEMLLPHTLQN | 6526 | Q8NDH2 | |
| SLPMTHSLKLSETNR | 186 | P11464 | |
| QQMSPSSLSALLSRQ | 366 | Q9P2E2 | |
| LMTLNTHSLLANIVP | 46 | P03901 | |
| QLHSPTNFLILSMAT | 61 | Q9P1P4 | |
| QTNLSPELSHMTLSP | 1291 | P12259 | |
| LTLPLNSDQTFHLMS | 396 | Q9H6L5 | |
| ANHLTTSMSGLSLQP | 331 | O95486 | |
| PKHSLTQISQSMLDL | 1481 | Q8IZX4 | |
| TLQATHSFLTMSPRQ | 621 | Q9H6K5 | |
| HSFLTMSPRQTQASL | 626 | Q9H6K5 | |
| LSNPTMLRTHSLSNA | 1581 | Q8IVL1 | |
| NHLVSLTMSGITTSL | 226 | Q9H4B7 | |
| HLMTNQTSQAPLLSF | 2346 | P08F94 | |
| MSQQHTLPVTLSPAL | 1 | P07476 | |
| SLPMTHSLQLSETNR | 186 | Q13046 | |
| TALDNKASLLHSMPT | 996 | O75122 | |
| ASPKMHRSVLSLNLN | 281 | Q96M02 | |
| TMPLSTSSHSLQQGQ | 551 | O95628 | |
| HLTLIDLSNNSISML | 776 | O75094 | |
| LDNPLSKLTTLNSMH | 231 | Q9BX84 | |
| ISLSLSHTNILMLDS | 146 | Q9NR96 | |
| QAGLSSSVHMLSLSI | 556 | Q7Z6L1 | |
| SSVHMLSLSITPAQT | 561 | Q7Z6L1 | |
| SISLMNLTSTPLCNL | 61 | Q8TCT8 | |
| SLALLANNLSMPTSD | 811 | Q9H0E3 | |
| LLNLSSTTPTHQESM | 486 | D6R9N7 | |
| LLNLSSSTPTHQESM | 486 | A8MUK1 | |
| LLNLSSSTPTHQESM | 486 | D6R901 | |
| LLNLSSSTPTHQESM | 486 | C9JLJ4 | |
| LLKLSSTTPTHQESM | 486 | D6RCP7 | |
| TSMLVSLLPTSLNAL | 266 | Q9P2E3 | |
| NISHTQTRLLSMAKP | 1531 | O75643 | |
| LLKLSSTTPTHQESM | 486 | C9JPN9 | |
| LLNLSSSTPTHQESM | 486 | Q0WX57 | |
| AFSHTSSLSQPQMLL | 266 | Q8N859 | |
| LSLSTLSRMLSTHNL | 201 | O75800 | |
| LLKLSSTTPTHQESM | 486 | D6RA61 | |
| SVQNQAMPSLTTSHL | 686 | O15016 | |
| KLESHLQNLSTLMAP | 1321 | Q6N021 | |
| LLNLSSTTPTHQESM | 486 | C9J2P7 | |
| LLNLSSSTPTHQESM | 486 | D6RBQ6 | |
| TVQALLSNSSMLPTL | 741 | P01266 | |
| LLNLSSTTPTHQESM | 486 | D6RJB6 | |
| LLNLSSTTPTHQESM | 486 | C9JVI0 | |
| SVSLSSSPNIMLLHR | 576 | Q8NI36 | |
| NSLHLLMETLNATTP | 641 | Q9Y4I1 | |
| SSGTPLHLSLTLQMN | 1051 | Q9Y2G1 | |
| LHLSLTLQMNSSSPV | 1056 | Q9Y2G1 | |
| SPTATMNNTHSNILR | 886 | Q13224 |